Literature DB >> 15987196

Apoptolidins B and C: isolation, structure determination, and biological activity.

Paul A Wender1, Martin Sukopp, Kate Longcore.   

Abstract

[reaction: see text] Apoptolidin (1) is a promising new therapeutic lead that exhibits remarkable selectivity against cancer cells relative to normal cells. We report the isolation, characterization, solution structure, stability, and biological activity of two new members of this family: apoptolidins B (2) and C (3). These new agents are found to have antiproliferative activity on par with or better than apoptolidin itself in an assay with H292 lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987196      PMCID: PMC2533581          DOI: 10.1021/ol051074o

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  16 in total

1.  Toward a structure-activity relationship for apoptolidin: selective functionalization of the hydroxyl group array.

Authors:  Paul A Wender; Orion D Jankowski; Elie A Tabet; Haruo Seto
Journal:  Org Lett       Date:  2003-02-20       Impact factor: 6.005

2.  Synthesis of termini-differentiated 6-carbon stereotetrads: an alkylative oxidation strategy for preparation of the c21-c26 segment of apoptolidin(1).

Authors:  Yuzhong Chen; Jerry B Evarts; Eduardo Torres; Philip L Fuchs
Journal:  Org Lett       Date:  2002-10-17       Impact factor: 6.005

3.  Total synthesis of apoptolidin: construction of enantiomerically pure fragments.

Authors:  K C Nicolaou; Konstantina C Fylaktakidou; Holger Monenschein; Yiwei Li; Bernd Weyershausen; Helen J Mitchell; Heng-xu Wei; Prasuna Guntupalli; David Hepworth; Kazuyuki Sugita
Journal:  J Am Chem Soc       Date:  2003-12-17       Impact factor: 15.419

4.  Facile synthetic access to and biological evaluation of the macrocyclic core of apoptolidin.

Authors:  Paul A Wender; Orion D Jankowski; Elie A Tabet; Haruo Seto
Journal:  Org Lett       Date:  2003-06-26       Impact factor: 6.005

5.  Structure-activity relationships within a family of selectively cytotoxic macrolide natural products.

Authors:  A R Salomon; Y Zhang; H Seto; C Khosla
Journal:  Org Lett       Date:  2001-01-11       Impact factor: 6.005

6.  Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase.

Authors:  A R Salomon; D W Voehringer; L A Herzenberg; C Khosla
Journal:  Chem Biol       Date:  2001-01

7.  Synthesis of the apoptosis inducing agent apoptolidin. Assembly of the C(16)-C(28) fragment.

Authors:  G A Sulikowski; W M Lee; B Jin; B Wu
Journal:  Org Lett       Date:  2000-05-18       Impact factor: 6.005

8.  Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase.

Authors:  A R Salomon; D W Voehringer; L A Herzenberg; C Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin.

Authors:  James D Pennington; Howard J Williams; Arthur R Salomon; Gary A Sulikowski
Journal:  Org Lett       Date:  2002-10-31       Impact factor: 6.005

10.  Isoapoptolidin: structure and activity of the ring-expanded isomer of apoptolidin.

Authors:  Paul A Wender; Aaron V Gulledge; Orion D Jankowski; Haruo Seto
Journal:  Org Lett       Date:  2002-10-31       Impact factor: 6.005

View more
  12 in total

1.  Biosynthesis of the Apoptolidins in Nocardiopsis sp. FU 40.

Authors:  Yu Du; Dagmara K Derewacz; Sean M Deguire; Jesse Teske; Jacques Ravel; Gary A Sulikowski; Brian O Bachmann
Journal:  Tetrahedron       Date:  2011-09-02       Impact factor: 2.457

Review 2.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

3.  Fluorescent probes of the apoptolidins and their utility in cellular localization studies.

Authors:  Sean M DeGuire; David C Earl; Yu Du; Brenda A Crews; Aaron T Jacobs; Alessandro Ustione; Cristina Daniel; Katherine M Chong; Lawrence J Marnett; David W Piston; Brian O Bachmann; Gary A Sulikowski
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-27       Impact factor: 15.336

4.  Amycolatopsins A-C: antimycobacterial glycosylated polyketide macrolides from the Australian soil Amycolatopsis sp. MST-108494.

Authors:  Zeinab G Khalil; Angela A Salim; Daniel Vuong; Andrew Crombie; Ernest Lacey; Antje Blumenthal; Robert J Capon
Journal:  J Antibiot (Tokyo)       Date:  2017-10-25       Impact factor: 2.649

5.  Light-induced isomerization of apoptolidin a leads to inversion of C2-C3 double bond geometry.

Authors:  Brian O Bachmann; Ruth McNees; Bruce J Melancon; Victor P Ghidu; Rachel Clark; Brenda C Crews; Sean M Deguire; Lawrence J Marnett; Gary A Sulikowski
Journal:  Org Lett       Date:  2010-07-02       Impact factor: 6.005

6.  The use of fluorescently-tagged apoptolidins in cellular uptake and response studies.

Authors:  Katherine M Chong; Nalin Leelatian; Sean M Deguire; Asa A Brockman; David Earl; Rebecca A Ihrie; Jonathan M Irish; Brian O Bachmann; Gary A Sulikowski
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

7.  Apoptolidins E and F, new glycosylated macrolactones isolated from Nocardiopsis sp.

Authors:  Paul A Wender; Kate E Longcore
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

8.  An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts.

Authors:  Chad A Lewis; Kate E Longcore; Scott J Miller; Paul A Wender
Journal:  J Nat Prod       Date:  2009-10       Impact factor: 4.050

9.  Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues.

Authors:  Paul A Wender; Orion D Jankowski; Kate Longcore; Elie A Tabet; Haruo Seto; Taijiro Tomikawa
Journal:  Org Lett       Date:  2006-02-16       Impact factor: 6.005

10.  Combined chemical and biosynthetic route to access a new apoptolidin congener.

Authors:  Victor P Ghidu; Ioanna Ntai; Jingqi Wang; Aaron T Jacobs; Lawrence J Marnett; Brian O Bachmann; Gary A Sulikowski
Journal:  Org Lett       Date:  2009-07-16       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.